The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1117696012 11176960 12 F 20150421 20160825 20150610 20160826 EXP DE-ROCHE-1567215 ROCHE 75.64 YR F Y 96.20000 KG 20160826 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1117696012 11176960 1 PS Trastuzumab TRASTUZUMAB 1 Subcutaneous Y U 20150200032,20150300064,20150300176 103792 600 MG SOLUTION FOR INJECTION Q3W
1117696012 11176960 2 SS Trastuzumab TRASTUZUMAB 1 Subcutaneous Y U 20150200032,20150300064,20150300176 103792 600 MG SOLUTION FOR INJECTION
1117696012 11176960 3 SS Trastuzumab TRASTUZUMAB 1 Subcutaneous Y U 20150200032,20150300064,20150300176 103792 600 MG SOLUTION FOR INJECTION
1117696012 11176960 4 SS PACLITAXEL ALBUMIN PACLITAXEL 1 Intravenous (not otherwise specified) 0 125 MG/M**2 /wk
1117696012 11176960 5 SS PACLITAXEL ALBUMIN PACLITAXEL 1 Intravenous (not otherwise specified) 0
1117696012 11176960 6 SS PACLITAXEL ALBUMIN PACLITAXEL 1 Intravenous (not otherwise specified) 0
1117696012 11176960 7 SS PACLITAXEL ALBUMIN PACLITAXEL 1 Intravenous (not otherwise specified) 0
1117696012 11176960 8 SS PACLITAXEL ALBUMIN PACLITAXEL 1 Intravenous (not otherwise specified) 0
1117696012 11176960 9 SS PACLITAXEL ALBUMIN PACLITAXEL 1 Intravenous (not otherwise specified) 0
1117696012 11176960 10 C DEXAMETHASON DEXAMETHASONE 1 Oral 0 8 MG /wk
1117696012 11176960 11 C AMLODIPIN AMLODIPINE BESYLATE 1 Oral 0 10 MG
1117696012 11176960 12 C VALSARTAN COMP HYDROCHLOROTHIAZIDEVALSARTAN 1 Oral 320/25 MG 0 BID
1117696012 11176960 13 C XARELTO RIVAROXABAN 1 0
1117696012 11176960 14 C ACTRAPID INSULIN HUMAN 1 0
1117696012 11176960 15 C PROTAPHANE INSULIN HUMAN 1 0
1117696012 11176960 16 C METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1117696012 11176960 1 Breast cancer
1117696012 11176960 4 Breast cancer
1117696012 11176960 10 Prophylaxis
1117696012 11176960 11 Hypertension
1117696012 11176960 12 Hypertension
1117696012 11176960 13 Atrial fibrillation
1117696012 11176960 14 Diabetes mellitus
1117696012 11176960 15 Diabetes mellitus

Outcome of event

Event ID CASEID OUTC COD
1117696012 11176960 OT
1117696012 11176960 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1117696012 11176960 Atrial fibrillation
1117696012 11176960 Cardiomyopathy
1117696012 11176960 Dry eye
1117696012 11176960 Nausea
1117696012 11176960 Pulmonary hypertension
1117696012 11176960 Right ventricular failure
1117696012 11176960 Ventricular extrasystoles

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1117696012 11176960 1 20150217 0
1117696012 11176960 2 20150310 20150421 0
1117696012 11176960 3 20150803 20160510 0
1117696012 11176960 4 20150217 20150408 0
1117696012 11176960 5 20150224 0
1117696012 11176960 6 20150303 0
1117696012 11176960 7 20150317 0
1117696012 11176960 8 20150324 0
1117696012 11176960 9 20150331 20150408 0
1117696012 11176960 10 20150217 20150408 0
1117696012 11176960 16 201504 0